IBI-10a(v) Accepted

Yellow Card System Prominence

Infected Blood Inquiry · Infected Blood Inquiry Final Report · Issued 20 May 2024 · Addressed to: UK Government

Source — verbatim from the inquiry

Inquiry recommendation

Steps be taken to give greater prominence to the online Yellow Card system to those receiving drugs or biological products, or who are being transfused with blood components.

Infected Blood Inquiry, Infected Blood Inquiry Final Report · 20 May 2024 Source PDF →

Published evidence summary

Publicly available evidence relating to this recommendation:

- The Government stated in December 2024 that the Yellow Card system was UK-wide and provided vital feedback, and that the MHRA was consulting on changes to reporting requirements for vaccines and blood components (Government Response to the Infected Blood Inquiry, Cabinet Office, December 2024).
- No published evidence of specific steps to give greater prominence to the Yellow Card system among recipients of drugs, biological products, or blood components has been identified to March 2026.

Response — verbatim from government

UK Government

The online Yellow Card system is UK wide and therefore this recommendation has been addressed on a UK wide basis. The Yellow Card system has provided vital feedback, but we agree with the inquiry that this deserves greater publicity.

The Medicines and Healthcare Regulatory Agency (MHRA) in collaboration with Serious Hazards of Transfusion (SHOT) have put plans in place and agreed a high-level curriculum to deliver blood training and awareness workshops.

The first workshops were delivered to the Welsh and South West region in January 2025, with a second workshop arranged to be delivered in Scotland in May.

User stories for the Yellow Card platform changes have been approved and are undergoing user acceptance testing for delivery by September 2025. A scoping meeting for final delivery of the changes is to be arranged.

Further promotional activities are planned via updates to the online Yellow Card platform, bulletins and the upcoming 60th Anniversary of the platform. The Yellow card 60th anniversary events publicised the MHRA yellow card function. Further opportunities will be made from MHRA events and conference invites where MHRA speak to raise awareness and further education about the Yellow Card scheme in relation to blood, working with patient organisations, other healthcare partners and Royal Colleges.

UK Government · 14 May 2025 Written response →

Evidence trail — what's actually happened since

  • 15 Jan 2026 · IBCA Community Update As of 13 January 2026: 3,721 people asked to start claims, 3,546 begun process, 3,074 received offers totalling £2.47bn, 2,861 paid totalling £1.89bn. Third compensation regulations in force 31 December 2025. View source → Good Progress

Each entry above links to a primary source — gov.uk written statement, consultation response document, or inspection report. The Index does not characterise government intent; it tracks what has been published.

How this page is built

Source and Response are verbatim from primary documents. The Evidence trail records published activity since — written statements, consultation outcomes, inspection findings, parliamentary references. The Index does not paraphrase or characterise intent; it tracks what has been published. Where the evidence is the absence of action (a missed deadline, a slipped timetable), that absence is documented from primary sources rather than inferred.

This recommendation's data is verified periodically against primary sources. The Index is monitored for staleness weekly.